Method for culturing postnatal substantia nigra as an in vitro model of experimental Parkinson's disease

被引:17
|
作者
Smeyne, M [1 ]
Smeyne, RJ [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA
来源
BRAIN RESEARCH PROTOCOLS | 2002年 / 9卷 / 02期
关键词
substantia nigra; Parkinson's disease; cell culture; N-methyl-4-phenyl-1,2,3,6 tetrahydropyridine hydrochloride (MPTP); glia; mice;
D O I
10.1016/S1385-299X(02)00117-4
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
One of the most prevalent degenerative disorders of the nervous system is Parkinson's disease. The etiology of this disease is for the most part unknown, although it is posited to arise from an interaction of genetic and environmental factors. Although in vivo animal studies have been used to examine the effects of a number of Parkinson-inducing compounds, there is little information on reliable in vitro methodologies that can recapitulate the previously observed in vivo results. Here, we describe a method for generating mixed and chimeric neuron/glial cultures of postnatal substantia nigra (SN), independent of other monoaminergic nuclei in the ventral midbrain. Since many toxins do not affect regions of the midbrain except the SN, use of whole ventral midbrain from embryos can dilute any measurement of cell death. By specifically culturing ventrolateral midbrain containing the substantia nigra, one can more directly target the effects of dopaminergic toxins. In addition, this method can be used to test potential therapies for amelioration of Parkinson's disease. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:105 / 111
页数:7
相关论文
共 50 条
  • [1] Postnatal decrease in substantia nigra echogenicityImplications for the pathogenesis of Parkinson’s disease
    Alexander Iova
    Andrew Garmashov
    Natalia Androuchtchenko
    Martin Kehrer
    Daniela Berg
    Georg Becker†
    Yurii Garmashov
    Journal of Neurology, 2004, 251 : 1451 - 1454
  • [2] Hyperechogenicity of the substantia nigra in Parkinson's disease
    Ressner, Pavel
    Skoloudik, David
    Hlustik, Petr
    Kanovsky, Petr
    JOURNAL OF NEUROIMAGING, 2007, 17 (02) : 164 - 167
  • [3] Irisin protects the substantia nigra dopaminergic neurons in the rat model of Parkinson's disease
    Zarbakhsh, Sam
    Safari, Manouchehr
    Aldaghi, Mohammad Reza
    Sameni, Hamid Reza
    Ghahari, Laya
    Lagmouj, Younes Khaleghi
    Jaberi, Khojasteh Rahimi
    Parsaie, Houman
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2019, 22 (07) : 722 - 728
  • [4] Postnatal decrease in substantia nigra echogenicity - Implications for the pathogenesis of Parkinson's disease
    Iova, A
    Garmashov, A
    Androuchtchenko, N
    Kehrer, M
    Berg, D
    Becker, G
    Garmashov, Y
    JOURNAL OF NEUROLOGY, 2004, 251 (12) : 1451 - 1454
  • [5] Proteomic change by Korean Red Ginseng in the substantia nigra of a Parkinson's disease mouse model
    Kim, Dongsoo
    Kwon, Sunoh
    Jeon, Hyongjun
    Ryu, Sun
    Ha, Ki-Tae
    Kim, Seungtae
    JOURNAL OF GINSENG RESEARCH, 2018, 42 (04) : 429 - 435
  • [6] Changes in Selenoprotein P in Substantia Nigra and Putamen in Parkinson's Disease
    Bellinger, Frederick P.
    Raman, Arjun V.
    Rueli, Rachel H.
    Bellinger, Miyoko T.
    Dewing, Andrea S.
    Seale, Lucia A.
    Andres, Marilou A.
    Uyehara-Lock, Jane H.
    White, Lon R.
    Ross, G. Webster
    Berry, Marla J.
    JOURNAL OF PARKINSONS DISEASE, 2012, 2 (02) : 115 - 126
  • [7] Substantia nigra hyperechogenicity in Parkinson’s disease
    Edson Bor-Seng-Shu
    Erich Talamoni Fonoff
    Egberto Reis Barbosa
    Manoel Jacobsen Teixeira
    Acta Neurochirurgica, 2010, 152 : 2085 - 2087
  • [8] Parkinson's disease: a novel MRI method for determining structural changes in the substantia nigra
    Hutchinson, M
    Raff, U
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 67 (06): : 815 - 818
  • [9] Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease
    R. K. B. Pearce
    A. Owen
    S. Daniel
    P. Jenner
    C. D. Marsden
    Journal of Neural Transmission, 1997, 104 : 661 - 677
  • [10] α-synuclein expression in substantia nigra and cortex in Parkinson's disease
    Neystat, M
    Lynch, T
    Przedborski, S
    Kholodilov, N
    Rzhetskaya, M
    Burke, RE
    MOVEMENT DISORDERS, 1999, 14 (03) : 417 - 422